Found: 8
Select item for more details and to access through your institution.
Personalized Medicine's Bottleneck: Diagnostic Test Evidence and Reimbursement.
- Published in:
- Journal of Personalized Medicine, 2014, v. 4, n. 2, p. 163, doi. 10.3390/jpm4020163
- By:
- Publication type:
- Article
Assessing Comparative Effectiveness Research in the US.
- Published in:
- Applied Health Economics & Health Policy, 2009, v. 7, n. 4, p. 219, doi. 10.1007/BF03256155
- By:
- Publication type:
- Article
Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment.
- Published in:
- Patient Preference & Adherence, 2019, v. 13, p. 1927, doi. 10.2147/PPA.S207908
- By:
- Publication type:
- Article
Rising Drug Costs Drives the Growth of Pharmacy Benefit Managers Exclusion Lists: Are Exclusion Decisions Value-Based?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Thinking of Others, and Ourselves.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Are payers treating orphan drugs differently?
- Published in:
- Journal of Market Access & Health Policy, 2014, v. 2, p. 1, doi. 10.3402/jmahp.v2.23513
- By:
- Publication type:
- Article
Finding legitimacy for the role of budget impact in drug reimbursement decisions.
- Published in:
- International Journal of Technology Assessment in Health Care, 2009, v. 25, n. 1, p. 49, doi. 10.1017/S0266462309090072
- By:
- Publication type:
- Article
Cost-effectiveness and Resource Allocation.
- Published in:
- 2006
- By:
- Publication type:
- Letter